SCHEMBL1327409

SCHEMBL1327409

[CH2]CCCCNCC=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7049537 0.97 PAOX (0.41)
SCHEMBL7049229 0.92
SCHEMBL3023756 0.89 PAOX (0.50)
SCHEMBL17291817 0.86 PAOX (0.48)
SCHEMBL17291826 0.86 PAOX (0.48)
SCHEMBL17291829 0.86 PAOX (0.48)
SCHEMBL5611725 0.86 PAOX (0.48)
Hydrochloric Acid SCHEMBL3024738 0.86 SMOX (0.52)
SCHEMBL17291809 0.86 PAOX (0.48)
SCHEMBL17291824 0.86 PAOX (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 280 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118255746-A Selective CDK12/13 inhibitors and uses thereof 南京圣和药业股份有限公司 2024-06-28 CN claimed
CN-118239963-A Compounds as eIF4E inhibitors and uses thereof 南京圣和药业股份有限公司 2024-06-25 CN claimed
CN-118234705-A Aspartic acid derivative and application thereof in treatment of liver fibrosis, nonalcoholic hepatitis and other metabolic diseases 深圳利沃生物医药科技有限公司 2024-06-21 CN claimed
US-RE49934-E1 Inhibitors of cellular metabolic processes SERVIER PHARMACEUTICALS LLC (US) 2024-04-23 US claimed
CN-117659050-A Quinazoline heterocyclic derivatives as KRAS mutation inhibitors for the treatment of cancer 深圳福沃药业有限公司 2024-03-08 CN claimed
WO-2023001045-A1 EXTERNAL ANTI-INFLAMMATORY COUPLING COMPOUND DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海椿安生物医药科技有限公司 2023-01-26 WO claimed
CN-110323079-B High-voltage-resistant anion exchange electrolyte membrane and solid-state battery capacitor thereof 中国科学院青岛生物能源与过程研究所 2021-08-27 CN claimed
WO-2021158792-A1 METHODS OF TREATING AUTOIMMUNE OR INFLAMMATORY DISEASES OR DISORDERS AGIOS PHARMACEUTICALS, INC. (US) 2021-08-12 WO claimed
WO-2021068755-A1 COMPOUND HAVING BRD4 INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF 上海海和药物研究开发股份有限公司 2021-04-15 WO claimed
US-10800782-B2 Inhibitors of cellular metabolic processes Agios Pharmaceutical, Inc. (US) 2020-10-13 US claimed
CN-1257489-A Substituted benzopyran derivatives for the treatment of inflammation SEARLE & CO (US) 2000-06-21 CN claimed
WO-1999047521-A1 HYPNOTIC β-CARBOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS MACEF (FR) 1999-09-23 WO claimed
CN-1190390-A Nitric oxide synthase inhibitors derived from cyclic amidines SEARLE & CO (US) 1998-08-12 CN claimed
CN-1189823-A Cyclic amidino formulations useful as nitric oxide synthase inhibitors SEARLE & CO (US) 1998-08-05 CN claimed
CN-1087092-A Novel 7 beta-substituted-4-aza-5 alpha-androstan-3-ones as 5 alpha-reductase inhibitors MERCK & CO INC (US) 1994-05-25 CN claimed
EP-0246114-B1 PHOTOCHROMIC SPIROPYRAN COMPOUNDS GEC-MARCONI LIMITED (GB) 1992-09-02 EP claimed
US-4826977-A Photochromic spiropyran compounds THE PLESSEY COMPANY PLC (GB) 1989-05-02 US claimed
CN-87104184-A PHOTOCHROMIC SPIROPYRAN COMPOUNDS 1988-06-29 CN claimed
EP-0246114-A2 Photochromic spiropyran compounds GEC-MARCONI LIMITED (GB) 1987-11-19 EP claimed
WO-1980000057-A1 CLEANING AGENT FOR DENTINE SURFACES DENTAL THERAPEUTICS AB (SE) 1980-01-24 WO claimed